These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 34785889)
1. Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats. Teaima M; Abdelmonem R; Adel YA; El-Nabarawi MA; El-Nawawy TM Drug Des Devel Ther; 2021; 15():4603-4614. PubMed ID: 34785889 [TBL] [Abstract][Full Text] [Related]
2. Cubosomal based oral tablet for controlled drug delivery of telmisartan: formulation, in-vitro evaluation and in-vivo comparative pharmacokinetic study in rabbits. Yasser M; Teaima M; El-Nabarawi M; El-Monem RA Drug Dev Ind Pharm; 2019 Jun; 45(6):981-994. PubMed ID: 30865478 [TBL] [Abstract][Full Text] [Related]
3. Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation. Albash R; Abdelbary AA; Refai H; El-Nabarawi MA Int J Nanomedicine; 2019; 14():1953-1968. PubMed ID: 30936696 [TBL] [Abstract][Full Text] [Related]
4. Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation. Aziz DE; Abdelbary AA; Elassasy AI Drug Deliv; 2018 Nov; 25(1):815-826. PubMed ID: 29557244 [TBL] [Abstract][Full Text] [Related]
5. Proniosomal Telmisartan Tablets: Formulation, in vitro Evaluation and in vivo Comparative Pharmacokinetic Study in Rabbits. Teaima MH; Yasser M; El-Nabarawi MA; Helal DA Drug Des Devel Ther; 2020; 14():1319-1331. PubMed ID: 32280201 [TBL] [Abstract][Full Text] [Related]
6. Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment. Albash R; El-Nabarawi MA; Refai H; Abdelbary AA Int J Nanomedicine; 2019; 14():6555-6574. PubMed ID: 31616143 [TBL] [Abstract][Full Text] [Related]
7. Transethosomes of Econazole Nitrate for Transdermal Delivery: Development, In-vitro Characterization, and Ex-vivo Assessment. Verma S; Utreja P Pharm Nanotechnol; 2018; 6(3):171-179. PubMed ID: 30101725 [TBL] [Abstract][Full Text] [Related]
8. Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations. Shreya AB; Managuli RS; Menon J; Kondapalli L; Hegde AR; Avadhani K; Shetty PK; Amirthalingam M; Kalthur G; Mutalik S J Liposome Res; 2016 Sep; 26(3):221-32. PubMed ID: 26621370 [TBL] [Abstract][Full Text] [Related]
9. Response Surface Optimization of Ultra-Elastic Nanovesicles Loaded with Deflazacort Tailored for Transdermal Delivery: Accentuated Bioavailability and Anti-Inflammatory Efficacy. Ali AA; Hassan AH; Eissa EM; Aboud HM Int J Nanomedicine; 2021; 16():591-607. PubMed ID: 33531803 [TBL] [Abstract][Full Text] [Related]
10. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies. Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361 [TBL] [Abstract][Full Text] [Related]
11. Nanotransethosomes for enhanced transdermal delivery of mangiferin against rheumatoid arthritis: formulation, characterization, invivo pharmacokinetic and pharmacodynamic evaluation. Adin SN; Gupta I; Rashid MA; Alhamhoom Y; Aqil M; Mujeeb M Drug Deliv; 2023 Dec; 30(1):2173338. PubMed ID: 36729134 [TBL] [Abstract][Full Text] [Related]
12. Ginger Extract-Loaded Transethosomes for Effective Transdermal Permeation and Anti-Inflammation in Rat Model. Hassan AS; Hofni A; Abourehab MAS; Abdel-Rahman IAM Int J Nanomedicine; 2023; 18():1259-1280. PubMed ID: 36945254 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous Optimization of Oral and Transdermal Nanovesicles for Bioavailability Enhancement of Ivabradine Hydrochloride. Naguib MJ; Elsayed I; Teaima MH Int J Nanomedicine; 2021; 16():2917-2931. PubMed ID: 33911861 [TBL] [Abstract][Full Text] [Related]
14. Low-Frequency versus High-Frequency Ultrasound-Mediated Transdermal Delivery of Agomelatine-Loaded Invasomes: Development, Optimization and in-vivo Pharmacokinetic Assessment. Tawfik MA; Tadros MI; Mohamed MI; Nageeb El-Helaly S Int J Nanomedicine; 2020; 15():8893-8910. PubMed ID: 33209023 [TBL] [Abstract][Full Text] [Related]
15. Formulation and Characterization of Nanosized Ethosomal Formulations of Antigout Model Drug (Febuxostat) Prepared by Cold Method: In Vitro/Ex Vivo and In Vivo Assessment. El-Shenawy AA; Abdelhafez WA; Ismail A; Kassem AA AAPS PharmSciTech; 2019 Dec; 21(1):31. PubMed ID: 31858305 [TBL] [Abstract][Full Text] [Related]
16. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment. Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906 [TBL] [Abstract][Full Text] [Related]
17. Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats. Bawazeer S; El-Telbany DFA; Al-Sawahli MM; Zayed G; Keed AAA; Abdelaziz AE; Abdel-Naby DH Drug Deliv; 2020 Dec; 27(1):1218-1230. PubMed ID: 32772730 [TBL] [Abstract][Full Text] [Related]
18. Iontophoretic Mediated Intraarticular Delivery of Deformable Liposomes of Diclofenac Sodium. Vanaja K; S S; Murthy SN; Shivakumar HN Curr Drug Deliv; 2021; 18(4):421-432. PubMed ID: 33059549 [TBL] [Abstract][Full Text] [Related]
19. Enhanced Transdermal Delivery of Bisoprolol Hemifumarate via Combined Effect of Iontophoresis and Chemical Enhancers: Ex Vivo Permeation/In Vivo Pharmacokinetic Studies. Teaima MH; Mohamed MAA; Abd El Rehem RT; Tayel SA; El-Nabarawi MA; Fouad SA Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34068544 [TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of proniosomes to enhance the transdermal delivery of cilostazole and to ensure the safety of its application. Nemr AA; El-Mahrouk GM; Badie HA Drug Dev Ind Pharm; 2021 Mar; 47(3):403-415. PubMed ID: 33625936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]